Search Results - "Benadiva, Claudio"

GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis by Engmann, Lawrence, Benadiva, Claudio, Humaidan, Peter

“…Abstract Gonadotrophin releasing hormone agonist (GnRHa) trigger is effective in the induction of oocyte maturation and prevention of ovarian hyperstimulation…”
Get full text

Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches by Humaidan, Peter, M.D, Engmann, Lawrence, M.D, Benadiva, Claudio, M.D

“…The challenges in attaining an adequate luteal phase after GnRH agonist (GnRHa) trigger to induce final oocyte maturation have resulted in different approaches…”
Get full text

Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization by Johnston-MacAnanny, Erika B., M.D, Hartnett, Janice, M.D, Engmann, Lawrence L., M.D, Nulsen, John C., M.D, Sanders, M. Melinda, M.D, Benadiva, Claudio A., M.D

“…Objective To determine the role of endometrial sampling for identification and treatment of chronic endometritis (CE) in patients undergoing IVF-ET who…”
Get full text

Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates by Griffin, Daniel, M.D, Feinn, Richard, Ph.D, Engmann, Lawrence, M.D, Nulsen, John, M.D, Budinetz, Tara, D.O, Benadiva, Claudio, M.D., H.C.L.D

“…Objective To evaluate the percentage (%) of mature oocytes retrieved in patients with a previous history of >25% immature oocytes retrieved who were triggered…”
Get full text

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study by Engmann, Lawrence, M.D, DiLuigi, Andrea, M.D, Schmidt, David, M.D, Nulsen, John, M.D, Maier, Donald, M.D, Benadiva, Claudio, M.D

“…Objective To determine whether there are any differences in the incidence of ovarian hyperstimulation syndrome (OHSS) and implantation rates in high-risk…”
Get full text

Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders by Griffin, Daniel, M.D, Benadiva, Claudio, M.D, Kummer, Nicole, M.D, Budinetz, Tara, D.O, Nulsen, John, M.D, Engmann, Lawrence, M.D

“…Objective To compare live birth rates after dual trigger of oocyte maturation with GnRH agonist (GnRHa) and low-dose hCG versus GnRHa alone in high responders…”
Get full text

The window is wide: flexible timing for vitrified–warmed embryo transfer in natural cycles by Bartels, Chantal B, Ditrio, Lauren, Grow, Daniel R, O'Sullivan, David M, Benadiva, Claudio A, Engmann, Lawrence, Nulsen, John C

“…What is the optimal timing for transfer in natural cycle vitrified–warmed embryo transfers (NC-VET)? This retrospective cohort study uses data from a large…”
Get full text

Survey assessing obesity policies for assisted reproductive technology in the United States by Kaye, Leah, M.D, Sueldo, Carolina, M.D, Engmann, Lawrence, M.D, Nulsen, John, M.D, Benadiva, Claudio, M.D., H.C.L.D

“…Objective To determine what assisted reproductive technologies (ART) policies, if any, have been instituted in response to an increasingly overweight and obese…”
Get full text

Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support by Engmann, Lawrence, M.D., M.R.C.O.G, Benadiva, Claudio, M.D., H.C.L.D

“…Although gonadotropin-releasing hormone agonist (GnRHa) trigger is effective in the prevention of ovarian hyperstimulation syndrome, lower conception rates…”
Get full text

Utilization of fertility treatment and reproductive choices by lesbian couples by Carpinello, Olivia J., M.D, Jacob, Mary Casey, Ph.D., A.B.P.P, Nulsen, John, M.D, Benadiva, Claudio, M.D., H.C.L.D

“…Objective To describe intentions and outcomes of lesbian couples requesting reproductive assistance; and report number of cycles needed to achieve a live…”
Get full text

Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GNRH agonist or HCG trigger for final oocyte maturation by Makhijani, Reeva, Thorne, Jeffrey, Bartels, Chantal, Bartolucci, Alison, Nulsen, John, Grow, Daniel, Benadiva, Claudio, Engmann, Lawrence

“…Purpose To assess whether GnRH agonist trigger impacts the implantation potential of euploid embryos. Methods Retrospective cohort study done at an academic…”
Get full text

Old habits die hard: retrospective analysis of outcomes with use of corticosteroids and antibiotics before embryo transfer by Kaye, Leah, M.D, Bartels, Chantal, M.D, Bartolucci, Alison, M.S, Engmann, Lawrence, M.D, Nulsen, John, M.D, Benadiva, Claudio, M.D

“…Objective To evaluate clinical pregnancy rates in embryo transfer (ET) cycles with and without peri-implantation corticosteroid and oral antibiotic…”
Get full text

Reduction in multiple pregnancy rate in donor oocyte–recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single-embryo transfer and preimplantation genetic testing by Makhijani, Reeva, Coulter, Madeline, Taggar, Arti, Godiwala, Prachi, O’Sullivan, David, Nulsen, John, Engmann, Lawrence, Benadiva, Claudio, Grow, Daniel

“…Purpose To evaluate the utilization of single-embryo transfer (SET) and preimplantation genetic testing (PGT) in gestational carrier IVF cycles in the USA with…”
Get full text

Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization by Budinetz, Tara H., D.O, Mann, Jessica S., M.D, Griffin, Daniel W., M.D, Benadiva, Claudio A., M.D, Nulsen, John C., M.D, Engmann, Lawrence L., M.D

“…Objective To compare the rate of congenital anomalies, obstetrical complications, and neonatal complications in antagonist cycles where either GnRH agonist…”
Get full text

A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders by DiLuigi, Andrea J., M.D, Engmann, Lawrence, M.D, Schmidt, David W., M.D, Benadiva, Claudio A., M.D, Nulsen, John C., M.D

“…We performed a randomized trial to compare IVF outcomes in 54 poor responder patients undergoing a microdose leuprolide acetate (LA) protocol or a GnRH…”
Get full text

Macroprolactinemia: a mini-review and update on clinical practice by Koniares, Katherine, Benadiva, Claudio, Engmann, Lawrence, Nulsen, John, Grow, Daniel

“…Hyperprolactinemia is common among infertile patients, with up to 15%–20% of women with oligomenorrhea having hyperprolactinemia. Suppression of the…”
Get full text

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting by DiLuigi, Andrea J., M.D, Engmann, Lawrence, M.D, Schmidt, David W., M.D, Maier, Donald B., M.D, Nulsen, John C., M.D, Benadiva, Claudio A., M.D

“…Ninety-four women undergoing IVF with peak E2 level >4000 pg/mL received leuprolide acetate (LA) trigger (LA trigger group) or had gonadotropins withheld for…”
Get full text

Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol by Budinetz, Tara H., D.O, Benadiva, Claudio A., M.D., H.C.L.D, Griffin, Daniel W., M.D, Engmann, Lawrence L., M.D, Nulsen, John C., M.D, DiLuigi, Andrea J., M.D

“…Objective To determine the ovulation rate after ovulation induction with clomiphene citrate (CC) in women who had previously been ovulatory after a stair-step…”
Get full text

New algorithm for OHSS prevention by Papanikolaou, Evangelos G, Humaidan, Peter, Polyzos, Nikos, Kalantaridou, Sofia, Kol, Sahar, Benadiva, Claudio, Tournaye, Herman, Tarlatzis, Basil

“…Ovarian hyperstimulation syndrome (OHSS) still remains a life-threatening complication of in vitro fertilization treatment (IVF), keeping patients and…”
Get full text

In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle by Kummer, Nicole E., M.D, Weitzman, Vanessa N., M.D, Benadiva, Claudio A., M.D, Schmidt, David W., M.D, Engmann, Lawrence L., M.D, Nulsen, John C., M.D

“…Patients undergoing controlled ovarian hyperstimulation and pituitary suppression with a GnRH antagonist who experienced a transient premature rise in LH were…”
Get full text